Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Vulvar Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Teratoma, Ovarian 1 Struma Ovarii 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Ovarian Neoplasms 1 Metabolic Syndrome 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Head and Neck Neoplasms 1 Genetic Predisposition to Disease 1 Disease 1 Diabetes Mellitus 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1

Interventions

Sorafenib 20 lenvatinib 18 Hepatectomy 17 Blood Specimen Collection 12 Immune Checkpoint Inhibitors 11 Liver Transplantation 9 atezolizumab 8 Surgical Procedures, Operative 7 Radiofrequency Ablation 7 Observation 7 Bevacizumab 6 regorafenib 5 gadolinium ethoxybenzyl DTPA 5 sintilimab 4 donafenib 4 camrelizumab 4 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 tislelizumab 3 spartalizumab 3 Polymerase Chain Reaction 3 Neoadjuvant Therapy 3 Mass Spectrometry 3 Immunohistochemistry 3 Doxorubicin 3 Angiogenesis Inhibitors 3 toripalimab 2 pembrolizumab 2 entecavir 2 apatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Carcinoma, Hepatocellular × DNA × Clear all

NCT05390112 2022-05-25

Mona-Lisa

University Hospital, Rouen

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡